González-González María Alejandra, Conde Silvia V, Latorre Ramon, Thébault Stéphanie C, Pratelli Marta, Spitzer Nicholas C, Verkhratsky Alexei, Tremblay Marie-Ève, Akcora Cuneyt G, Hernández-Reynoso Ana G, Ecker Melanie, Coates Jayme, Vincent Kathleen L, Ma Brandy
Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, Houston, TX, United States.
Department of Pediatric Neurology, Baylor College of Medicine, Houston, TX, United States.
Front Integr Neurosci. 2024 Feb 19;18:1321872. doi: 10.3389/fnint.2024.1321872. eCollection 2024.
Bioelectronic Medicine stands as an emerging field that rapidly evolves and offers distinctive clinical benefits, alongside unique challenges. It consists of the modulation of the nervous system by precise delivery of electrical current for the treatment of clinical conditions, such as post-stroke movement recovery or drug-resistant disorders. The unquestionable clinical impact of Bioelectronic Medicine is underscored by the successful translation to humans in the last decades, and the long list of preclinical studies. Given the emergency of accelerating the progress in new neuromodulation treatments (i.e., drug-resistant hypertension, autoimmune and degenerative diseases), collaboration between multiple fields is imperative. This work intends to foster multidisciplinary work and bring together different fields to provide the fundamental basis underlying Bioelectronic Medicine. In this review we will go from the biophysics of the cell membrane, which we consider the inner core of neuromodulation, to patient care. We will discuss the recently discovered mechanism of neurotransmission switching and how it will impact neuromodulation design, and we will provide an update on neuronal and glial basis in health and disease. The advances in biomedical technology have facilitated the collection of large amounts of data, thereby introducing new challenges in data analysis. We will discuss the current approaches and challenges in high throughput data analysis, encompassing big data, networks, artificial intelligence, and internet of things. Emphasis will be placed on understanding the electrochemical properties of neural interfaces, along with the integration of biocompatible and reliable materials and compliance with biomedical regulations for translational applications. Preclinical validation is foundational to the translational process, and we will discuss the critical aspects of such animal studies. Finally, we will focus on the patient point-of-care and challenges in neuromodulation as the ultimate goal of bioelectronic medicine. This review is a call to scientists from different fields to work together with a common endeavor: accelerate the decoding and modulation of the nervous system in a new era of therapeutic possibilities.
生物电子医学是一个快速发展的新兴领域,它在带来独特临床益处的同时,也面临着独特的挑战。它包括通过精确输送电流来调节神经系统,以治疗诸如中风后运动恢复或耐药性疾病等临床病症。生物电子医学在过去几十年成功转化应用于人体以及众多临床前研究,都凸显了其不容置疑的临床影响力。鉴于加快新型神经调节治疗(如耐药性高血压、自身免疫性疾病和退行性疾病)进展的紧迫性,多个领域之间的合作势在必行。这项工作旨在促进多学科合作,汇聚不同领域,为生物电子医学提供基础依据。在本综述中,我们将从细胞膜生物物理学(我们认为这是神经调节的核心)入手,一直探讨到患者护理。我们将讨论最近发现的神经传递转换机制及其对神经调节设计的影响,还将介绍健康和疾病状态下神经元及神经胶质细胞的最新研究进展。生物医学技术的进步促进了大量数据的收集,从而在数据分析方面带来了新的挑战。我们将讨论高通量数据分析中的当前方法和挑战,包括大数据、网络、人工智能和物联网。重点将放在理解神经接口的电化学特性,以及生物相容性和可靠材料的整合,以及符合转化应用的生物医学法规。临床前验证是转化过程的基础,我们将讨论此类动物研究的关键方面。最后,我们将聚焦患者护理以及神经调节面临的挑战,这也是生物电子医学的最终目标。本综述呼吁不同领域的科学家共同努力:在治疗可能性的新时代加速对神经系统的解码和调节。